...

TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President


03/15/2018

TriCore Contact:
Dr. Nick Dayan
Chief Administrative Officer
(505) 938-8991
Nicholas.Dayan@tricore.org
 
TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President
 
For Immediate Release (Albuquerque, New Mexico) - March 6, 2018 – TriCore Reference Laboratories is pleased to announce that the board of directors has appointed Michael Crossey, MD, PhD, to the position of CEO and president, effective immediately.
Dr. Crossey’s appointment is a clear reflection of the company’s current state: Ready to take on the future!  Robin Divine, chair of TriCore’s board of directors, stated: “Enormous opportunity for TriCore lies ahead.  We couldn’t be happier with Dr. Crossey accepting this position and moving us down the path of continued success.”
For the past 20 years since TriCore’s inception, Dr. Crossey has served the organization in various capacities, from pathologist to chief medical officer to interim chief executive officer.  He brings decades of experience and internationally recognized expertise in clinical laboratory medicine to the company.
Says Dr. Crossey of his new position: “I'm honored, and I'm grateful to the board for the opportunity to lead this exceptional organization of creative, dedicated and talented professionals."
###
 Michael Crossey, MD, PhD, CEO/CMO
 
TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide. 
For more information, visit tricore.org.
 

TriCore in the News

Too few technologists: labs take inventive steps

The tight supply of technologists to fill open positions is pushing laboratories to be creative in finding answers. Memorial Sloan Kettering Cancer Center and TriCore Reference Laboratories found their answers by looking not just outward but also—and largely—inward.

CAP Today, April 2019,05/10/2019

Companies Focus on Helping Labs do More with Less

With no end in sight to the lab workforce shortage, vendors aim to fill the gap

AACC,04/09/2019

Practical challenges in peripheral blood smear evaluation

Unlike high-count monoclonal B-cell lymphocytosis, low-count MBL has a limited chance of progression to CLL and thus there is no need for follow-up. And a definitive diagnosis of T-cell large granulocytic leukemia requires demonstration of clonality. Those and other points were made in a CAP18 session on practical challenges in peripheral blood evaluation.

CAP Today,03/25/2019

Improving the Delivery of Healthcare through Clinical Diagnostic Insights: A Valuation of Laboratory Medicine through "Clinical Lab 2.0"

As healthcare payment and reimbursement begin to shift from a fee-for-service to a value-based model, ancillary providers including laboratories must incorporate this into their business strategy. Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation. Current literature in this area is limited.

Journal of Applied Laboratory Medicine,03/05/2019

Recent Tweets

Follow us on Twitter